Literature DB >> 2619152

Ocular toxicity of tamoxifen.

E W Gerner1.   

Abstract

Tamoxifen is a preferred agent for the treatment of breast cancer. While efficacious, it is not without serious side effects. Ocular toxicity to the cornea, retina, and optic nerve have been reported. We present a case of tamoxifen retinopathy and emphasize the need for periodic ophthalmologic examinations to prevent loss of vision.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619152

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  11 in total

1.  Tamoxifen retinopathy: a rare but serious complication.

Authors:  C R Bentley; G Davies; W A Aclimandos
Journal:  BMJ       Date:  1992-02-22

2.  Antifibrotic effect of tamoxifen in a model of progressive renal disease.

Authors:  Humberto Dellê; José Roberto C Rocha; Rita C Cavaglieri; José Mauro Vieira; Denise M A C Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

3.  Lens opacification by antioestrogens: tamoxifen vs ICI 182,780.

Authors:  J J Zhang; T J Jacob; S P Hardy; C F Higgins; M A Valverde
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

Authors:  J J Zhang; T J Jacob; M A Valverde; S P Hardy; G M Mintenig; F V Sepúlveda; D R Gill; S C Hyde; A E Trezise; C F Higgins
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

5.  [Tamoxifen retinopathy: a case series of clinical and functional data].

Authors:  C Ritter; A B Renner; J Wachtlin; N E Bechrakis; L Krause
Journal:  Ophthalmologe       Date:  2008-06       Impact factor: 1.059

6.  Phase I trial of droloxifene in patients with metastatic breast cancer.

Authors:  A U Buzdar; S Kau; G N Hortobagyi; R L Theriault; D Booser; F A Holmes; R Walters; I H Krakoff
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Retinal function in patients treated with tamoxifen.

Authors:  Sung Eun Song Watanabe; Adriana Berezovsky; Márcia Motono; Paula Yuri Sacai; Josenilson Martins Pereira; Juliana Maria Ferraz Sallum; Luiz Henrique Gebrim; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2010-04       Impact factor: 2.379

Review 8.  Drug-induced macular edema.

Authors:  Olga E Makri; Ilias Georgalas; Constantine D Georgakopoulos
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 9.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

Review 10.  A risk-benefit assessment of tamoxifen therapy.

Authors:  W H Catherino; V C Jordan
Journal:  Drug Saf       Date:  1993-05       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.